KR20010050060A - A novel process for preparing 1-substituted-5-hydroxymethyl imidazole - Google Patents
A novel process for preparing 1-substituted-5-hydroxymethyl imidazole Download PDFInfo
- Publication number
- KR20010050060A KR20010050060A KR1020000046738A KR20000046738A KR20010050060A KR 20010050060 A KR20010050060 A KR 20010050060A KR 1020000046738 A KR1020000046738 A KR 1020000046738A KR 20000046738 A KR20000046738 A KR 20000046738A KR 20010050060 A KR20010050060 A KR 20010050060A
- Authority
- KR
- South Korea
- Prior art keywords
- substituted
- formula
- alkyl
- thiol
- hydroxymethylimidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 하기 화학식 1의 1-치환된-5-하이드록시메틸 이미다졸의 제조방법에 관한 것으로서, 더욱 구체적으로는 하기 화학식 2의 1-치환된-5-하이드록시메틸이미다졸-2-티올의 2번 위치를 수소로 치환하여 화학식 1의 화합물을 제조하는 방법에 관한 것이다:The present invention relates to a process for preparing 1-substituted-5-hydroxymethyl imidazole of formula (1), more specifically 1-substituted-5-hydroxymethylimidazole-2- of formula (2) To a method of preparing a compound of Formula 1 by substituting hydrogen for position 2 of thiol:
[화학식 1][Formula 1]
[화학식 2][Formula 2]
상기식에서, R 은 알킬, 하이드록시알킬, 알릴, 또는 각각 치환 또는 비치환된 아릴메틸 또는 디아릴메틸이며, 바람직하게는, C1-4알킬, 하이드록시C1-4알킬, 알릴, 벤질, 치환된 벤질, 특히, 할로겐으로 치환된 벤질, 3,4-디옥시메틸렌벤질 또는 2-아릴메틸이다.Wherein R is alkyl, hydroxyalkyl, allyl, or substituted or unsubstituted arylmethyl or diarylmethyl, respectively, preferably C 1-4 alkyl, hydroxyC 1-4 alkyl, allyl, benzyl, Substituted benzyl, in particular benzyl substituted by halogen, 3,4-dioxymethylenebenzyl or 2-arylmethyl.
상기 화학식 1의 1-치환된-5-하이드록시메틸 이미다졸은 현재 개발중인 각종 항암제, 특히 파네실 전이효소 억제제 계통의 항암제 제조에 있어서 유용하다고 알려진 핵심 중간체이다(참조 : Ko, J.S. et al., PCT 국제출원 공개 WO 9905117 A1 19990204, p129).The 1-substituted-5-hydroxymethyl imidazole of Formula 1 is a key intermediate known to be useful in the preparation of various anticancer agents, especially in the anti-cancer agents of the panesyl transferase inhibitor system (see Ko, JS et al. , PCT International Application Publication WO 9905117 A1 19990204, p129).
상기 화학식 2의 화합물로부터 상기 화학식 1의 화합물을 제조하는 방법에 있어서, 종래 보편적으로 이용되던 방법은 진한 질산, 또는 진한 질산과 촉매량의 아질산염을 이용하여 가온함으로써 2번 위치에 치환되어 있던 티올기를 제거하는 것으로서(참조 : R.G. Jones, J.Amer.Chem.Soc., 1949,71, 383), 경제적이며 실험실적으로 조작이 간단한 장점이 있다. 그러나 이 제조 방법은 과량의 진한 질산을 사용함으로써 반응 종결 후 중화시 발열이 심하고, 다량의 가스가 발생하며, 반응이 가온된 상태에서 매우 급격히 한 순간에 일어남으로써 가스의 발생과 함께 부피의 팽창이 수반되어 산업적 생산에서의 안전을 확보할 수가 없다. 또한 가장 중요한 문제점으로서, 가온된 상태에서 방향족 고리에 친전자성 니트로화 반응이 부반응으로 수반되는 단점이 있으므로 이러한 문제를 개선한 새로운 제조 방법을 개발하게 되었다.In the method for preparing the compound of Chemical Formula 1 from the compound of Chemical Formula 2, a conventionally used method removes thiol groups substituted at position 2 by heating with concentrated nitric acid or concentrated nitric acid and a catalytic amount of nitrite. (RG Jones, J. Amer. Chem. Soc., 1949, 71, 383), which has the advantage of being economically and laboratoryly simple to operate. However, this manufacturing method uses excessive concentrated nitric acid, which causes severe heat generation during the neutralization after the completion of the reaction, a large amount of gas is generated, and occurs rapidly at a moment while the reaction is warmed. It is not possible to secure safety in industrial production. In addition, the most important problem is that the electrophilic nitration reaction to the aromatic ring in the warm state is accompanied by the disadvantages of the side reaction has been developed a new manufacturing method that improves this problem.
5-하이드록시메틸 이미다졸의 제조에 있어서 상기한 문제점들을 해결할 수 있는 새로운 제조 방법을 개발하기 위하여 본 발명자들은 집중적인 연구를 수행하였다.In order to develop a new production method that can solve the above problems in the preparation of 5-hydroxymethyl imidazole, the inventors conducted extensive research.
티올기를 술폰산으로 산화시키는데 있어서, 진한 질산을 이용하거나 진한 염산과 과산화수소수를 이용하는 보고들(참조 : Cech,J., Collect. Czech. Chem. Commun., 1949,14, 558)과 술파이드를 산화하여 술폭시드 또는 술폰으로 전환하는 반응들(참조 : Vernier,C.G., et al., J.Org.Chem., 1982,47, 3773 ; Edwards,D., J.Chem.Soc., 1954, 3272 ; Paquette, L.A.,Org.Synth., 1985,64, 157 ; Watanabe, Y., Synthesis, 1981, 204 ; Ho,T.L., Synthesis, 1972,561 ; Djerassi,C, J.Amer. Chem.Soc., 1953,75, 3838 등)은 많은 문헌에 보고되었고 본 기술분야에서 통상적으로 사용되는 예가 많이 있다. 그러나 전술한 바와 같이 많은 문헌에도 불구하고 본 발명에서 유용한, 티올기의 산화적 절단은 그 예를 찾기 어려워 산업적으로 바람직한 촉매를 이용하여 제조하는 방법을 연구하던 중, 전이금속 촉매 및 산화제로서 과산화수소수 등을 이용하는 경우, 온화한 반응 조건에서 목적하는 이미다졸 유도체를 고순도로 용이하게 얻을 수 있음을 확인하고 본 발명을 완성하게 되었다.In the oxidation of thiol groups to sulfonic acids, reports using either concentrated nitric acid or concentrated hydrochloric acid and hydrogen peroxide (see Cech, J., Collect. Czech.Chem. Commun., 1949, 14, 558) and sulfides Reactions to sulfoxides or sulfones (Vernier, CG, et al., J. Org. Chem., 1982, 47, 3773; Edwards, D., J. Chem. Soc., 1954, 3272; Paquette, LA, Org. Synth., 1985, 64, 157; Watanabe, Y., Synthesis, 1981, 204; Ho, TL, Synthesis, 1972, 561; Djerassi, C, J. Amer. Chem. Soc., 1953 , 75, 3838, etc.) have been reported in many literatures and there are many examples commonly used in the art. However, in spite of many documents as described above, the oxidative cleavage of thiol groups, which is useful in the present invention, is difficult to find an example of, and while studying a method for producing using an industrially preferred catalyst, hydrogen peroxide as a transition metal catalyst and oxidant When used, etc., it was confirmed that the desired imidazole derivative can be easily obtained with high purity under mild reaction conditions, and the present invention was completed.
본 발명은 하기 화학식 2의 1-치환된-5-하이드록시메틸이미다졸-2-티올을 용매중에서 전이금속 촉매와 과산화수소수 등의 산화제 존재하에 반응시켜 하기 화학식 1의 1-치환된-5-하이드록시메틸 이미다졸을 제조하는 방법에 관한 것이다:The present invention reacts 1-substituted-5-hydroxymethylimidazole-2-thiol of formula (2) in the presence of an oxidizing agent such as a transition metal catalyst and hydrogen peroxide in a solvent to 1-substituted-5 of formula (1) To a process for preparing hydroxymethyl imidazole:
[화학식 1][Formula 1]
[화학식 2][Formula 2]
상기식에서, R 은 알킬, 하이드록시알킬, 알릴, 또는 각각 치환 또는 비치환된 아릴메틸 또는 디아릴메틸 등이며, 바람직하게는, C1-4알킬, 하이드록시C1-4알킬, 알릴, 벤질, 치환된 벤질, 특히, 할로겐으로 치환된 벤질, 3,4-디옥시메틸렌벤질 또는 2-아릴메틸 등이다.Wherein R is alkyl, hydroxyalkyl, allyl, or substituted or unsubstituted arylmethyl or diarylmethyl, and the like, preferably C 1-4 alkyl, hydroxyC 1-4 alkyl, allyl, benzyl Substituted benzyl, in particular benzyl substituted by halogen, 3,4-dioxymethylenebenzyl or 2-arylmethyl and the like.
그러나, 상기 언급한 치환기 이외의 통상의 치환기들도 별도의 언급없이 적용될 수 있다.However, conventional substituents other than the aforementioned substituents may also be applied without further mention.
상기 정의에서 알킬은 직쇄 또는 측쇄 알킬이다.Alkyl in the above definition is straight or branched alkyl.
본 발명을 더욱 구체적으로 설명하면 다음과 같다.The present invention is explained in more detail as follows.
1-번 위치가 치환된-5-하이드록시메틸이미다졸-2-티올을 물 또는 수용성용매계 또는 이들의 혼합계에서 촉매량의 전이금속 존재하에서 당량적 산화제를 가하여 실온 내지 승온에서 반응시킨다. 이러한 방법으로 1-치환된-5-하이드록시메틸이미다졸-2-티올을 매우 용이하게 1-치환된-5-하이드록시메틸 이미다졸로 전환시킬 수 있다.The 5-substituted 5-hydroxymethylimidazole-2-thiol substituted at 1-position is reacted at room temperature to elevated temperature by adding an equivalent oxidizing agent in the presence of a catalytic amount of transition metal in water or a water-soluble solvent system or a mixture thereof. In this way, the 1-substituted-5-hydroxymethylimidazole-2-thiol can be very easily converted to 1-substituted-5-hydroxymethyl imidazole.
본 발명의 제조방법에서 사용되는 촉매로는 산화능력을 가지는 여러 전이금속, 예를 들어 바나듐, 크롬, 몰리브덴, 망간, 텅스텐, 레늄, 루테늄, 오스뮴 등을 사용할 수 있는데, 그 중 레늄, 루테늄, 오스뮴 등은 값이 비싼 단점이 있고, 바나듐, 크롬, 망간, 텅스텐등은 비교적 저렴하므로 산업적 측면을 고려할 때 이들 전이 금속이 바람직하다. 더욱 바람직한 전이 금속 촉매로는 텅스텐산(H2WO4), 산화바나듐 (V2O5) 또는 황산바나듐(VOSO4)이다. 출발물질인 화학식 2의 1-치환된-5-하이드록시메틸이미다졸-2-티올 대 촉매로 사용되는 전이금속, 예를 들어, 텅스텐산(H2WO4), 산화바나듐(V2O5) 또는 황산바나듐(VOSO4)의 몰 비율은 통상 5:1 내지 1000:1 이며 바람직하게는 50:1 내지 1000:1이다.As a catalyst used in the preparation method of the present invention, various transition metals having oxidizing ability, for example, vanadium, chromium, molybdenum, manganese, tungsten, rhenium, ruthenium, osmium, and the like can be used, among which rhenium, ruthenium, osmium Etc. are expensive, and vanadium, chromium, manganese, tungsten, etc. are relatively inexpensive, and these transition metals are preferable in consideration of industrial aspects. More preferred transition metal catalysts are tungstic acid (H 2 WO 4 ), vanadium oxide (V 2 O 5 ) or vanadium sulfate (VOSO 4 ). Starting materials 1-substituted-5-hydroxymethylimidazole-2-thiol of Formula 2 vs. transition metals used as catalysts, for example tungstic acid (H 2 WO 4 ), vanadium oxide (V 2 O 5 ) or vanadium sulfate (VOSO 4 ) is usually 5: 1 to 1000: 1 and preferably 50: 1 to 1000: 1.
본 발명에 있어서 유용한 당량적 산화제로는 과산화수소수, 알킬과산화수소수(t-부틸하이드로겐퍼옥사이드 등) 또는 알칼리차아염소산염(나트륨 또는 칼슘)이 적합하며, 그 중에서도 10% 내지 30%의 과산화수소수가 더욱 바람직하다. 화학식 1의 화합물에 대하여 3-10몰 당량 사용한다.As the equivalent oxidizing agent useful in the present invention, hydrogen peroxide, alkyl hydrogen peroxide (t-butylhydrogen peroxide, etc.) or alkali hypochlorite (sodium or calcium) is suitable, among which 10% to 30% of hydrogen peroxide is more preferable. Do. 3-10 molar equivalents are used with respect to the compound of formula 1.
반응 용매로는 물 또는 수용성 용매계, 바람직하게는 저급 알콜류 또는 이들의 혼합계가 사용되며, 가장 바람직하게는 물, 메탄올, 에탄올 또는 그 혼합계가 사용된다.As the reaction solvent, water or a water-soluble solvent system, preferably lower alcohols or a mixture thereof is used, most preferably water, methanol, ethanol or a mixture thereof.
반응 온도는 30 내지 100℃에서 반응시킬 수 있으며, 바람직하게는 50 내지 70℃, 더욱 바람직하게는 40 내지 70℃에서 반응시킨다. 또한 반응은 통상적으로 화학식 2의 1-치환된-5-하이드록시메틸이미다졸-2-티올을 화학식 1의 1-치환된-5-하이드록시메틸 이미다졸로 전환시키는 반응이 실질적으로 종료될 때까지 진행시키며, 바람직하게는 2 내지 6시간 진행시킨다.The reaction temperature can be reacted at 30 to 100 ° C, preferably at 50 to 70 ° C, more preferably at 40 to 70 ° C. In addition, the reaction is generally substantially terminated by the conversion of the 1-substituted-5-hydroxymethylimidazole-2-thiol of formula (2) to 1-substituted-5-hydroxymethyl imidazole of formula (1). Progress until, preferably 2 to 6 hours.
반응이 종결된 후, 반응 혼합물을 단순히 염기성화하여 생성된 고체를 여과하거나 또는 염기성화한 후 적당한 용매, 예를 들면 디클로로메탄 또는 클로로포름으로 추출하고 필요에 따라 통상 사용되는 적당한 용매, 예를 들면 n-헥산 또는 이소프로필에테르 등으로 처리하여 더욱 정제함으로써 목적 생성물, 즉 1-치환된-5-하이드록시메틸 이미다졸을 반응 혼합물로부터 고순도로 용이하게 회수할 수 있다.After completion of the reaction, the reaction mixture is simply basified to give a solid or the resulting solid is filtered off or basified and then extracted with a suitable solvent, for example dichloromethane or chloroform and, if necessary, a suitable solvent commonly used, for example n By further purification by treatment with -hexane or isopropyl ether, the desired product, i.e., 1-substituted-5-hydroxymethyl imidazole, can be easily recovered from the reaction mixture in high purity.
본 발명은 하기 실시예에 의하여 더욱 구체적으로 설명되나, 본 발명의 범위가 이들에 의하여 어떤 식으로든 제한되는 것은 아니다.The invention is illustrated in more detail by the following examples, although the scope of the invention is not limited in any way by these.
제조예 1 : 1-벤질-5-하이드록시메틸이미다졸-2-티올의 제조Preparation Example 1 Preparation of 1-benzyl-5-hydroxymethylimidazole-2-thiol
벤질아민 염산염(14.36g, 0.1mol)과 1,3-디하이드록시아세톤 이량체(18g, 0.1mol)를 100㎖ 이소프로판올에 잘 현탁한 뒤 티오시아네이트 칼륨염(14.6g, 0.15mol)을 첨가하였다. 상기 현탁액에 초산(19.22g, 0.32mol)을 적가한 뒤 실온에서 24시간 교반하였다. 상기 반응액에 증류수 50㎖를 첨가한 다음 약 0.5시간 더 교반하고 여과한 다음 증류수 50㎖로 두번 세척한 뒤 이소프로필에테르 50㎖로 두번 세척하여 상기 백색 고체분말을 얻고 이를 약 3시간 동안 건조하여 일정 중량의 생성물을 수득하였다. 이러한 방법에 의해 순수한 1-벤질-5-하이드록시메틸이미다졸-2-티올 20.4g(수율 92.6%)을 최종적으로 수득하였다.Benzylamine hydrochloride (14.36 g, 0.1 mol) and 1,3-dihydroxyacetone dimer (18 g, 0.1 mol) are well suspended in 100 ml isopropanol and then thiocyanate potassium salt (14.6 g, 0.15 mol) is added. It was. Acetic acid (19.22 g, 0.32 mol) was added dropwise to the suspension, followed by stirring at room temperature for 24 hours. 50 ml of distilled water was added to the reaction solution, followed by further stirring for about 0.5 hours, filtered, washed twice with 50 ml of distilled water, and then twice with 50 ml of isopropyl ether to obtain the white solid powder, which was dried for about 3 hours. A certain weight of product was obtained. By this method 20.4 g (yield 92.6%) of pure 1-benzyl-5-hydroxymethylimidazole-2-thiol was finally obtained.
1H NMR(500MHz, DMSO-d6) δ 12.15(1H. s), 7.32(2H, t, J=7.3Hz), 7.26(1H, d, J=7.3Hz), 7.24(2H, t, J=7.3Hz), 6.85(1H, s), 5.32(2H, s), 5.25(1H, s), 4.14(2H, d, J=5Hz) 1 H NMR (500 MHz, DMSO-d 6 ) δ 12.15 (1H.s), 7.32 (2H, t, J = 7.3 Hz), 7.26 (1H, d, J = 7.3 Hz), 7.24 (2H, t, J = 7.3 Hz), 6.85 (1H, s), 5.32 (2H, s), 5.25 (1H, s), 4.14 (2H, d, J = 5 Hz)
제조예 2 : 여러가지 이미다졸-2-티올 유도체의 제조Preparation Example 2 Preparation of Various Imidazole-2-Thiol Derivatives
제조예 1과 유사한 방법으로 여러가지 이미다졸-2-티올 유도체를 제조하였고 그 결과를 아래 표에 나타내었다.Various imidazole-2-thiol derivatives were prepared in a similar manner to Preparation Example 1 and the results are shown in the table below.
제조예 3 : 1-알릴-5-하이드록시메틸이미다졸-2-티올의 제조Preparation Example 3 Preparation of 1-allyl-5-hydroxymethylimidazole-2-thiol
알릴아민 염산염 0.1몰을 상기 제조예 1과 같은 방법으로 23시간 반응시킨 다음 증류수 40㎖를 첨가하고 반응혼합물을 감압증류하여 약 1/3 부피가 되도록 하였다. 침전물을 여과하고 증류수 30㎖로 두 번, 이소프로필에테르30㎖로 두 번 세척하고 건조하여 백색 분말을 12.5g(수율 72.6%) 수득하였다.0.1 mol of allylamine hydrochloride was reacted for 23 hours in the same manner as in Preparation Example 1, and 40 ml of distilled water was added thereto, and the reaction mixture was distilled under reduced pressure to about 1/3 volume. The precipitate was filtered, washed twice with 30 ml of distilled water, twice with 30 ml of isopropyl ether and dried to give 12.5 g (yield 72.6%) of white powder.
1H NMR(500MHz, DMSO-d6) δ 12.03(1H, s), 6.81(1H, s), 5.89(1H, m), 5.21(1H, -OH), 5.12(1H, dd, J1=10.5Hz, J2=1.4Hz), 4.97(1H, dd, J1=14.4Hz, J2=1.4Hz), 4.67(2H, s), 4.28(2H, s) 1 H NMR (500 MHz, DMSO-d 6 ) δ 12.03 (1H, s), 6.81 (1H, s), 5.89 (1H, m), 5.21 (1H, -OH), 5.12 (1H, dd, J 1 = 10.5Hz, J 2 = 1.4Hz), 4.97 (1H, dd, J 1 = 14.4Hz, J 2 = 1.4Hz), 4.67 (2H, s), 4.28 (2H, s)
제조예 4 : 1-(3-하이드록시프로필)-5-하이드록시메틸이미다졸-2-티올의 제조Preparation Example 4 Preparation of 1- (3-hydroxypropyl) -5-hydroxymethylimidazole-2-thiol
제조예 1과 유사한 방법으로 1-(3-하이드록시프로필)-5-하이드록시메틸이미다졸-2-티올을 69% 수율로 얻고 그의 구조를1H NMR로 확인하였다.In a similar manner to Preparation Example 1, 1- (3-hydroxypropyl) -5-hydroxymethylimidazole-2-thiol was obtained in 69% yield and its structure was confirmed by 1 H NMR.
1H NMR(500MHz, DMSO-d6) δ 11.96(1H, s), 6.80(1H, s), 5.19(1H, -OH), 4.56(1H, -OH), 4.35(2H, s), 4.02(2H, t, 7.3Hz), 3.40(2H, m), 1.85(2H, t, J=7.3Hz) 1 H NMR (500MHz, DMSO-d 6 ) δ 11.96 (1H, s), 6.80 (1H, s), 5.19 (1H, -OH), 4.56 (1H, -OH), 4.35 (2H, s), 4.02 (2H, t, 7.3 Hz), 3.40 (2H, m), 1.85 (2H, t, J = 7.3 Hz)
실시예 1 : 1-벤질-5-하이드록시메틸 이미다졸의 제조Example 1 Preparation of 1-benzyl-5-hydroxymethyl imidazole
1-벤질-5-하이드록시메틸이미다졸-2-티올(2.2g, 9.99mmol) 과 텅스텐산 (H2WO4, 25mg, 1mol%)을 메탄올 11㎖에 혼합한 뒤 수조에서 40℃로 가온하여 교반하면서 30% 과산화수소수(3.75g, 3.2몰당량)를 5분간 적가하였다. 이때 반응혼합물의 온도가 65℃로 상승되어 환류되기 시작하였고 그 온도에서 2.5시간 교반하였다. 출발물질이 다 소모되었을 때 얼음수조로 냉각하고 1N 가성소다 수용액(18㎖)으로 pH를 10으로 맞추었다. 생성된 고체를 약 15분간 더 교반한 다음 여과하고 증류수 15㎖로 두번 세척한 뒤 이소프로필에테르 15㎖로 두번 세척하여 건조하여 표제화합물을 흰색 분말로 1.3g(수율 69%, HPLC순도 96.7%)을 수득하였다.1-benzyl-5-hydroxymethylimidazole-2-thiol (2.2 g, 9.99 mmol) and tungstic acid (H 2 WO 4 , 25 mg, 1 mol%) were mixed in 11 ml of methanol and then heated to 40 ° C. in a water bath. 30% hydrogen peroxide (3.75 g, 3.2 molar equivalents) was added dropwise for 5 minutes while warming and stirring. At this time, the temperature of the reaction mixture was increased to 65 ℃ to reflux and stirred at that temperature for 2.5 hours. When the starting material was exhausted, the mixture was cooled with an ice bath and the pH was adjusted to 10 with 1N aqueous sodium hydroxide solution (18 ml). The resulting solid was further stirred for about 15 minutes, filtered, washed twice with 15 ml of distilled water, twice with 15 ml of isopropyl ether and dried to give 1.3 g of the title compound as a white powder (yield 69%, HPLC purity 96.7%). Obtained.
1H NMR (500MHz, DMSO-d6) δ 7.67(1H, s), 7.35(2H, t, J=7.3Hz), 7.28(1H, t, J=7.3Hz), 7.17(2H, d, J=7.3Hz), 6.82(1H, s), 5.23(2H, s), 5.11(1H, t, -OH), 4.32(2H, d, J=5.5Hz) 1 H NMR (500 MHz, DMSO-d 6 ) δ 7.67 (1H, s), 7.35 (2H, t, J = 7.3 Hz), 7.28 (1H, t, J = 7.3 Hz), 7.17 (2H, d, J = 7.3 Hz), 6.82 (1H, s), 5.23 (2H, s), 5.11 (1H, t, -OH), 4.32 (2H, d, J = 5.5 Hz)
13C NMR (125MHz, DMSO-d6) δ 163.15, 137.68, 130.91, 128.97, 127.78, 127.40, 113.39, 53.88, 46.97 13 C NMR (125 MHz, DMSO-d 6 ) δ 163.15, 137.68, 130.91, 128.97, 127.78, 127.40, 113.39, 53.88, 46.97
실시예 2 : 1-(4-브로모벤질)-5-하이드록시메틸 이미다졸의 제조Example 2 Preparation of 1- (4-bromobenzyl) -5-hydroxymethyl imidazole
1-(4-브로모벤질)-5-하이드록시메틸이미다졸-2-티올(1.5g, 5mmol)과 텅스텐산 12.5mg(1mol%)를 메탄올 7㎖에 현탁하고 40℃ 가량 가온한 뒤 30% 과산화수소수를 천천히 적가하였다. 약 2시간 후 냉각하고 1N 가성소다용액으로 중화한 뒤 침전물을 여과하였다. 얻어진 고체를 증류수 5㎖로 두번, 이소프로필에테르로 두번 세척하여 백색 분말을 1.1g(수율 82%) 수득하였다.1- (4-bromobenzyl) -5-hydroxymethylimidazole-2-thiol (1.5 g, 5 mmol) and 12.5 mg (1 mol%) of tungstic acid were suspended in 7 ml of methanol and warmed up to about 40 ° C. 30% hydrogen peroxide solution was slowly added dropwise. After about 2 hours, the mixture was cooled, neutralized with 1N caustic soda solution, and the precipitate was filtered. The obtained solid was washed twice with 5 ml of distilled water and twice with isopropyl ether to obtain 1.1 g (yield 82%) of white powder.
1H NMR (500MHz, DMSO-d6) δ 7.68(1H, s), 7.54(2H, dd, J1= 6.4Hz, J2=1.8Hz), 7.12(2H, dd, J1=6.4Hz, J2=1.8Hz), 6.83(1H, s), 5.21(2H, s), 5.12(1H, s, -OH), 4.32(2H, d, Jgem=3.25Hz) 1 H NMR (500 MHz, DMSO-d 6 ) δ 7.68 (1H, s), 7.54 (2H, dd, J 1 = 6.4 Hz, J 2 = 1.8 Hz), 7.12 (2H, dd, J 1 = 6.4 Hz, J 2 = 1.8 Hz), 6.83 (1H, s), 5.21 (2H, s), 5.12 (1H, s, -OH), 4.32 (2H, d, J gem = 3.25 Hz)
13C NMR (125MHz, DMSO-d6) δ 139.04, 137.66, 132.07, 129.83, 128.08, 121.22, 113.75, 53.33, 47.45 13 C NMR (125 MHz, DMSO-d 6 ) δ 139.04, 137.66, 132.07, 129.83, 128.08, 121.22, 113.75, 53.33, 47.45
실시예 3 : 1-(3-브로모벤질)-5-하이드록시메틸 이미다졸의 제조Example 3: Preparation of 1- (3-bromobenzyl) -5-hydroxymethyl imidazole
1-(3-브로모벤질)-5-하이드록시메틸이미다졸-2-티올을 상기 실시예 2와 같은 방법으로 반응시켜 목적화합물을 75% 수율로 깨끗이 수득하였다.1- (3-bromobenzyl) -5-hydroxymethylimidazole-2-thiol was reacted in the same manner as in Example 2 to obtain the target compound in 75% yield.
1H NMR (500MHz, DMSO-d6) δ 7.71(1H, s), 7.49(1H, d, J= 7.8Hz), 7.37(1H, s), 7.31(1H, t, J=7.8Hz), 7.16(1H, d, J=7.8Hz), 6.84(1H, s), 5.24(sH, s), 5.13(1H, s, -OH), 4.32(2H, d, Jgem=4.6Hz) 1 H NMR (500 MHz, DMSO-d 6 ) δ 7.71 (1H, s), 7.49 (1H, d, J = 7.8 Hz), 7.37 (1H, s), 7.31 (1H, t, J = 7.8 Hz), 7.16 (1H, d, J = 7.8 Hz), 6.84 (1H, s), 5.24 (sH, s), 5.13 (1H, s, -OH), 4.32 (2H, d, J gem = 4.6 Hz)
13C NMR (125MHz, DMSO-d6) δ 141.02, 139.11, 132.14, 131.34, 130.96, 130.31, 128.08, 126.67, 124.42, 53.28, 47.35 13 C NMR (125 MHz, DMSO-d 6 ) δ 141.02, 139.11, 132.14, 131.34, 130.96, 130.31, 128.08, 126.67, 124.42, 53.28, 47.35
실시예 4 : 1-(3,4-디옥시메틸렌벤질)-5-하이드록시메틸 이미다졸의 제조Example 4 Preparation of 1- (3,4-Dioxymethylenebenzyl) -5-hydroxymethyl imidazole
1-(3,4-디옥시메틸렌벤질)-5-하이드록시메틸이미다졸-2-티올 (2.64g, 10mmol)과 산화바나듐(V2O5, 18mg, 1mol%)를 에탄올 10㎖와 증류수 10㎖에 현탁한 뒤 50℃ 가량 가온하면서 30% 과산화수소수를 천천히 적가하였다. 1시간 뒤 냉각하여 1N 가성소다로 pH를 10으로 조정한 뒤 여과하고 증류수 15㎖로 두번, 이소프로필에테르로 두번 세척한 후 건조하여 백색 분말을 2.05g(수율 88%)을 수득하였다.10 ml of 1- (3,4-dioxymethylenebenzyl) -5-hydroxymethylimidazole-2-thiol (2.64 g, 10 mmol) and vanadium oxide (V 2 O 5 , 18 mg, 1 mol%) with ethanol Suspended in 10 ml of distilled water and then slowly added dropwise 30% hydrogen peroxide solution while warming 50 ℃. After cooling for 1 hour, the pH was adjusted to 10 with 1N caustic soda, filtered, washed twice with 15 ml of distilled water, twice with isopropyl ether, and dried to obtain 2.05 g (yield 88%) of white powder.
1H NMR (500MHz, DMSO-d6) δ 7.64(1H, s), 6.87(1H, d, J= 7.5Hz), 6.79(2x1H, s), 6.70(1H, d, J=7.5Hz), 5.99(2H, s), 5.10(2H, s and 1H, s, -OH), 4.34(2H, s) 1 H NMR (500 MHz, DMSO-d 6 ) δ 7.64 (1H, s), 6.87 (1H, d, J = 7.5 Hz), 6.79 (2x1H, s), 6.70 (1H, d, J = 7.5 Hz), 5.99 (2H, s), 5.10 (2H, s and 1H, s, -OH), 4.34 (2H, s)
13C NMR(125MHz, DMSO-d6) δ 148.06, 147.23, 138.82, 132.09, 131.84, 127.93, 121.28, 108.80, 108.40, 101.62, 53.34, 47.87 13 C NMR (125 MHz, DMSO-d 6 ) δ 148.06, 147.23, 138.82, 132.09, 131.84, 127.93, 121.28, 108.80, 108.40, 101.62, 53.34, 47.87
실시예 5 : 1-에틸-5-하이드록시메틸 이미다졸의 제조Example 5 Preparation of 1-ethyl-5-hydroxymethyl imidazole
1-에틸-5-하이드록시메틸이미다졸-2-티올을 상기 실시예 1과 같은 방법으로 반응시킨 다음 잔사를 여과하는 대신 클로로포름으로 추출하여 목적화합물을 68% 수율로 수득하였다.1-ethyl-5-hydroxymethylimidazole-2-thiol was reacted in the same manner as in Example 1, and the residue was extracted with chloroform instead of filtration to obtain the target compound in 68% yield.
1H NMR (500MHz, DMSO-d6) δ 7.59(1H, s), 6.76(1H, s), 4.43(2H, 2), 3.99(2H, q, J=7.3Hz), 1.33(3H, t, J=7.3Hz) 1 H NMR (500 MHz, DMSO-d 6 ) δ 7.59 (1H, s), 6.76 (1H, s), 4.43 (2H, 2), 3.99 (2H, q, J = 7.3 Hz), 1.33 (3H, t , J = 7.3 Hz)
13C NMR(125MHz, DMSO-d6) δ 137.83, 131.85, 127.69, 60.92, 53.15, 16.93 13 C NMR (125 MHz, DMSO-d 6 ) δ 137.83, 131.85, 127.69, 60.92, 53.15, 16.93
실시예 6 : 1-알릴-5-하이드록시메틸 이미다졸의 제조Example 6 Preparation of 1-allyl-5-hydroxymethyl imidazole
1-알릴-5-하이드록시메틸이미다졸-2-티올을 상기 실시예 1과 같은 방법으로 반응시키고, 잔사를 여과하는 대신 n-부탄올로 추출하여 목적화합물을 76% 수득하였다.1-allyl-5-hydroxymethylimidazole-2-thiol was reacted in the same manner as in Example 1, and the residue was extracted with n-butanol instead of filtration to obtain 76% of the title compound.
1H NMR (500MHz, DMSO-d6) δ 7.54(1H, s), 6.79(1H, s), 6.00(1H, ddd, J1=20Hz, J2=10Hz, J3=5.5Hz), 6.15(1H, dd, J1=10Hz, J2=1.35Hz), 4.98(1H, dd, J1=16.95Hz, J2=1.35Hz), 4.64(2H, dd, J1=5.5Hz, J2=1.35Hz), 4.39(2H, s) 1 H NMR (500MHz, DMSO-d 6 ) δ 7.54 (1H, s), 6.79 (1H, s), 6.00 (1H, ddd, J 1 = 20Hz, J 2 = 10Hz, J 3 = 5.5Hz), 6.15 (1H, dd, J 1 = 10Hz, J 2 = 1.35Hz), 4.98 (1H, dd, J 1 = 16.95Hz, J 2 = 1.35Hz), 4.64 (2H, dd, J 1 = 5.5Hz, J 2 = 1.35 Hz), 4.39 (2H, s)
13C NMR(125MHz, DMSO-d6) δ 138.47, 135.15, 132.19, 127.72, 117.37, 60.91, 47.07 13 C NMR (125 MHz, DMSO-d 6 ) δ 138.47, 135.15, 132.19, 127.72, 117.37, 60.91, 47.07
실시예 7 : 1-(3-하이드록시프로필)-5-하이드록시메틸 이미다졸의 제조Example 7 Preparation of 1- (3-hydroxypropyl) -5-hydroxymethyl imidazole
1-(3-하이드록시프로필)-5-하이드록시메틸이미다졸-2-티올 (5.0g, 23.1mmol)과 텅스텐산(H2WO4, 58mg, 1mol%)을 메탄올 25㎖와 증류수 25㎖에 혼합하고 40℃로 가온한 다음 30% 과산화수소수 3.6g을 적가하였다. 약 15분간 교반하고 냉각한 후 1N 가성소다로 염기성화하고 n-부탄올 25㎖로 2번 추출한 뒤 용매를 감압증류하여 목적화합물을 3.45g(수율 80.7%) 수득하였다.1- (3-hydroxypropyl) -5-hydroxymethylimidazole-2-thiol (5.0 g, 23.1 mmol) and tungstic acid (H 2 WO 4 , 58 mg, 1 mol%) were diluted with 25 mL of methanol and 25 mL of distilled water. The mixture was mixed with mL, warmed to 40 DEG C, and 3.6 g of 30% hydrogen peroxide solution was added dropwise. After stirring for about 15 minutes and cooling, the mixture was basified with 1N caustic soda, extracted twice with 25 ml of n-butanol, and the solvent was distilled under reduced pressure to obtain 3.45 g (yield 80.7%) of the title compound.
1H NMR (500MHz, CDCl3) δ 7.46(1H, s), 6.91(1H, s), 4.61(2H, s), 4.15(2H, t, J=7Hz), 3.52(2H, t, J=7Hz), 2.01(2H, m) 1 H NMR (500 MHz, CDCl 3 ) δ 7.46 (1H, s), 6.91 (1H, s), 4.61 (2H, s), 4.15 (2H, t, J = 7 Hz), 3.52 (2H, t, J = 7 Hz), 2.01 (2H, m)
실시예 8 : 1-(4-브로모벤질)-5-하이드록시메틸 이미다졸의 제조Example 8 Preparation of 1- (4-bromobenzyl) -5-hydroxymethyl imidazole
1-(4-브로모벤질)-5-하이드록시메틸이미다졸-2-티올(40g, 0.134mol)과 황산바나듐 수화물 21.9mg(0.1mol%)을 에탄올 240㎖ 과 물 240㎖ 의 혼합용액에 넣고, 약 45℃로 가온하여 교반하였다. 잠시 후, 30% 과산화수소수(51.6g, 3.4mol 당량)를 천천히 적가하면서, 내부 온도가 약 50℃를 유지하도록 하였다. 반응 초기의 흰색 현탁액이 반응이 진행되면서 연황색 용액으로 바뀌면 약 30분간 더 교반하고, 6N 수산화나트륨 용액을 가하여 pH 를 약 10 으로 조절하였다. 이후, 에탄올을 감압증류하였다. 이때, 침전된 결정을 여과하고, 증류수로 세척한 후, 무게가 일정해 질 때까지 건조시켜 백색 분말의 표제 화합물 28.7g (수율 80.4%, HPLC = 97%) 을 수득하였다.A mixed solution of 1- (4-bromobenzyl) -5-hydroxymethylimidazole-2-thiol (40 g, 0.134 mol) and 21.9 mg (0.1 mol%) of vanadium sulfate hydrate in 240 ml of ethanol and 240 ml of water Into, stirred at about 45 ° C. After a while, 30% hydrogen peroxide water (51.6 g, 3.4 mol equivalent) was slowly added dropwise while maintaining the internal temperature at about 50 ° C. When the white suspension at the beginning of the reaction turned into a pale yellow solution as the reaction proceeded, the mixture was further stirred for about 30 minutes, and the pH was adjusted to about 10 by adding 6N sodium hydroxide solution. Thereafter, ethanol was distilled under reduced pressure. At this time, the precipitated crystals were filtered, washed with distilled water, and dried until constant weight to give 28.7 g (80.4% yield, HPLC = 97%) of the title compound as a white powder.
1H NMR (δ, ppm, DMSO-d6) 7.68(1H, s), 7.54(2H, d, J=8.3Hz), 7.12(2H, d, J=8.3Hz), 6.82(1H, s), 5.21(2H, s), 5.09(1H, t, J=5.5Hz), 4.31(2H, s) 1 H NMR (δ, ppm, DMSO-d 6 ) 7.68 (1H, s), 7.54 (2H, d, J = 8.3 Hz), 7.12 (2H, d, J = 8.3 Hz), 6.82 (1H, s) , 5.21 (2H, s), 5.09 (1H, t, J = 5.5 Hz), 4.31 (2H, s)
실시예 9 : 1-(3,4-디옥시메틸렌벤질)-5-하이드록시메틸 이미다졸의 제조Example 9 Preparation of 1- (3,4-Dioxymethylenebenzyl) -5-hydroxymethyl imidazole
1-(3,4-디옥시메틸렌벤질)-5-하이드록시메틸이미다졸-2-티올(22.15kg, 83.8mol)과 황산바나듐 수화물 11g (0.1mol%)을 반응기에 넣고, 47.1kg의 에탄올과 55kg의 정제수를 가하여 교반하면서, 반응액을 44℃로 조절하였다. 상기 현탁액에 32.2kg 의 30% 과산화수소수를 40 내지 60℃의 범위에서 서서히 가하고, 46℃에서 교반한 뒤, 6N 수산화나트륨 용액을 가하여 pH 를 약 10 으로 조절하였다. 이후, 에탄올을 감압증류하였다. 증류가 완료된 후, 상온으로 냉각시키고, 여과하고, 정제수로 세척한 후, 건조시켜 미색 분말의 표제 화합물 11.5kg (수율 59.9%, HPLC = 96.6%) 을 수득하였다.1- (3,4-dioxymethylenebenzyl) -5-hydroxymethylimidazole-2-thiol (22.15 kg, 83.8 mol) and 11 g (0.1 mol%) of vanadium sulfate hydrate were placed in a reactor and 47.1 kg of Ethanol and 55 kg of purified water were added thereto, and the reaction solution was adjusted to 44 ° C. while stirring. 32.2 kg of 30% hydrogen peroxide water was slowly added to the suspension in the range of 40 to 60 ° C., stirred at 46 ° C., and 6N sodium hydroxide solution was added to adjust the pH to about 10. Thereafter, ethanol was distilled under reduced pressure. After the distillation was completed, cooled to room temperature, filtered, washed with purified water and dried to give 11.5 kg (yield 59.9%, HPLC = 96.6%) of the title compound as an off-white powder.
1H NMR (δ, ppm, DMSO-d6) 7.64(1H, s), 6.87(1H, d, J=7.8Hz), 6.79(2H, s), 6.69(1H, d, J=7.8Hz), 5.99(2H, s), 5.10(2H, s), 4.34(2H, s) 1 H NMR (δ, ppm, DMSO-d 6 ) 7.64 (1H, s), 6.87 (1H, d, J = 7.8 Hz), 6.79 (2H, s), 6.69 (1H, d, J = 7.8 Hz) , 5.99 (2H, s), 5.10 (2H, s), 4.34 (2H, s)
상기한 바와 같이 본 발명의 방법에 의해 얻은 생성물인 1-치환된-5-하이드록시메틸 이미다졸은 공지된 화합물로서 최종적으로 J. S. Ko 등의 특허 (PCT 국제출원 공개 WO 9905117 A1 19990204, p129)에 기재되어 있는 특정 파네실 전이효소 억제제 계통의 항암제를 제조하는데 유용한 중간체이다.As described above, the product obtained by the method of the present invention, 1-substituted-5-hydroxymethyl imidazole, is a known compound and finally is disclosed in the patent of JS Ko et al. (PCT International Application Publication No. WO 9905117 A1 19990204, p129). It is an intermediate useful for preparing anticancer agents of the specific panesyl transferase inhibitor family described.
본 발명에 따른 신규 제조 방법은 독특한 티올기의 산화적 제거방법에 의해 5-하이드록시메틸 이미다졸 유도체로 알려진 유용한 중간체를 순수하고 높은 수율로 제공하며, 반응의 안전성과 신뢰성에서 종전의 기술을 크게 개선하였다. 따라서, 본 발명의 제조 방법은 위험한 진한 질산의 사용을 피함으로써 그 위험을 현저히 제거하여 산업적 대량생산에 매우 적합하다.The novel production process according to the present invention provides useful intermediates, known as 5-hydroxymethyl imidazole derivatives, in pure and high yield by a unique method of oxidative removal of thiol groups, and greatly improves upon previous techniques in the safety and reliability of the reaction. Improved. Therefore, the production method of the present invention is very suitable for industrial mass production by significantly eliminating the risk by avoiding the use of dangerous concentrated nitric acid.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990037652 | 1999-09-06 | ||
KR19990037652 | 1999-09-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010050060A true KR20010050060A (en) | 2001-06-15 |
KR100388788B1 KR100388788B1 (en) | 2003-06-25 |
Family
ID=19610212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0046738A KR100388788B1 (en) | 1999-09-06 | 2000-08-12 | A novel process for preparing 1-substituted-5-hydroxymethyl imidazole |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100388788B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010026648A (en) * | 1999-09-08 | 2001-04-06 | 성재갑 | A novel process for preparing N-alkyloxycarbonyl-β-alkylsulfonylvaline |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI833794A0 (en) * | 1983-10-18 | 1983-10-18 | Farmos Oy | SUBSTITUERADE 2-MERKAPTO-IMIDAZOLER |
GB9422391D0 (en) * | 1994-11-05 | 1995-01-04 | Solvay Interox Ltd | Oxidation of organosulphur compounds |
WO2000001674A1 (en) * | 1998-07-01 | 2000-01-13 | Merck & Co., Inc. | Process for making 1,5-disubstituted imidazoles |
AU7040500A (en) * | 1999-09-06 | 2001-04-10 | Lg Chem Investment Ltd. | Process for preparing a 1-substituted 5-hydroxymethyl imidazole |
-
2000
- 2000-08-12 KR KR10-2000-0046738A patent/KR100388788B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010026648A (en) * | 1999-09-08 | 2001-04-06 | 성재갑 | A novel process for preparing N-alkyloxycarbonyl-β-alkylsulfonylvaline |
Also Published As
Publication number | Publication date |
---|---|
KR100388788B1 (en) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4097109B1 (en) | Process for the synthesis of buprenorphine | |
CN114380741A (en) | Preparation method of 4-position alkylated derivative of 2-methylquinoline compound | |
JPH02212475A (en) | Preparation of 2-chloro-5-chloromethylpyridine | |
KR100388788B1 (en) | A novel process for preparing 1-substituted-5-hydroxymethyl imidazole | |
EP1116719B1 (en) | 3-(1-Hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one, a process for the preparation thereof and the use thereof | |
JP2825132B2 (en) | New method for producing compounds | |
MX2011000994A (en) | Method for producing phenylalkane-1-ols. | |
US6630593B1 (en) | Process for preparing a 1-substituted 5-hydroxymethyl imidazole | |
KR100302346B1 (en) | A method of preparing 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline | |
JPS624247A (en) | Manufacture of 4,4'-dinitrodibenzyls | |
US4925970A (en) | Process for producing cyclohexadiene thioether | |
AU2018389809A1 (en) | A process for the preparation of crisaborole | |
US20030162975A1 (en) | Method for preparing substituted 5-amino-n-phenyl-1,2,4-triazole-3-sulfonamides | |
JPH0780851B2 (en) | 2,3,5-Trimethylpyridine derivative and process for producing the same | |
US4990648A (en) | Process for producing an alkylthiobenzoate | |
GB2160204A (en) | Preparation of N-methyl-1-alkylthio-2-nitroethenamines | |
KR20030066594A (en) | Intermediates for use in the preparation of vitamin e | |
JPH07196610A (en) | Production of 5-chloro-2-oxyindole | |
JP2769179B2 (en) | Method for producing 2-phenylbenzotriazoles | |
JP4293504B2 (en) | Process for producing N-substituted formylimidazoles | |
KR900003882B1 (en) | Process for the preparation of compounds with h2 antihistamine activity | |
KR950005192B1 (en) | Making method of p-methoxycinnamine acid | |
JPH04243867A (en) | Production of 2-chloro-4-pyridinemethanol | |
KR970001473B1 (en) | Method for preparing pyrazole sulfonyl chloride derivatives | |
JPH0159266B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20060417 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |